What is the catalog number for Peroxiredoxin 4/PRDX4 Rabbit Polyclonal Antibody?

The catalog number for Peroxiredoxin 4/PRDX4 Rabbit Polyclonal Antibody is orb76350.

What sizes are available for Peroxiredoxin 4/PRDX4 Rabbit Polyclonal Antibody?

Peroxiredoxin 4/PRDX4 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Peroxiredoxin 4/PRDX4 Rabbit Polyclonal Antibody in stock?

Peroxiredoxin 4/PRDX4 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Peroxiredoxin 4/PRDX4 Rabbit Polyclonal Antibody

Anti-Peroxiredoxin 4/PRDX4 Antibody. Tested in WB applications. This antibody reacts with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

Peroxiredoxin-4; 1.11.1.15; Antioxidant enzyme AOE372; AOE37-2; Peroxiredoxin IV; Prx-IV; Thioredoxin peroxidase AO372; Thioredoxin-dependent peroxide reductase A0372; PRDX4

UniProt

Q13162

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of human Peroxiredoxin 4, identical to the related mouse and rat sequences.

Target

Peroxiredoxin-4

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cell Biology, Metabolism Research

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Rat, Mouse

Form

Lyophilized

Molecular Weight

26 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.